06
contents
/////// ISSUE NO. 5, 2019
SPECIAL CLINICAL SECTION: NEUROLOGY
STUDY OF CANNABINOIDS' POTENTIAL TO TREAT
MS SYMPTOMS YIELDS MIXED RESULTS 13
Patients with multiple sclerosis can safely use medicina l
cannabinoids to treat symptoms, but the relief may be slight,
research suggests.
ZEROING IN ON COFFEE'S POTENTIAL USE
AGAINST NEURODEGENERATIVE DISEASE 14
Scientists are gaining insights about the mechanisms of
coffee's neuroprotective effects.
DEPARTMENTS
PRODUCT SPOTLIGHT 02
DATA VAULT 05
08
10
FE ATURES
ADVANCED NEUROMODULATION THERAPY
PROVIDES RELIEF FROM CHRONIC PAIN FOR
LOCAL PATIENTS 06
The latest in neuromodulation therapy, dorsa l root ganglion
stimulation, can produce significant qua lity-of-life
improvement for patients with chronic neuropathic pain.
IMMERSIVE 3D TECHNOLOGY ENHANCES
NEUROSURGICAL OUTCOMES AT PENN STATE
HEALTH MILTON S. HERSHEY MEDICAL CENTER 08
Among the first U.S. facilities to perform surgery using the
Olympus OR BEYE, the Milton S. Hershey Medica l Center
leverages this technolog y to ma ke brain and spine surgeries
more precise.
EDUCATING A NEW GENERATION: THE MILTON S.
HERSHEY MEDICAL CENTER'S INNOVATIVE
NEUROSURGERY RESIDENCY TRAINING PROGRAM 10
Neurosurgery residents at Hershey Medica l Center train
under leading specia lists in the field in an expanded program
that prioritizes excellence and innovation.
